Our #healthandmedicalresearch workforce is under growing pressure. We must inspire students early, strengthen career pathways and invest in researcher #wellbeing. A sustainable workforce means better #health outcomes. Read @ResAustralia's INSPIRE Issue 38: researchaustralia.org/inspir…

Are our learnings from COVID positioning us effectively to deal with any future pandemics? The @nhmrc says Australia isn't ready for 'Disease X'. Read the full story: researchprofessionalnews.com… 📸: SB Arts Media, via Adobe Stock #COVID19 #pandemics #healthresearch

Great to see #MRFF funds being used to support research and emerging researchers in such an important area: health.gov.au/news/mrff-677-… #health #ageing @ausgov

How is AI influencing medical research, clinical trials and diagnosis of disease? Delve into this new feature for @ResAustralia INSPIRE Magazine, where Professor Edward Holmes, past recipient of the GSK Award for Research Excellence (ARE), and Executive Country Medical Director Dr Alan Paul, discuss how the application of AI is translating into clinical impact. Professor Holmes received the 2025 GSK ARE for his pioneering use of metatranscriptomics and AI to quickly identify viruses, improve diagnostics, and better understand how infectious disease epidemics emerge. A tool that enables more rapid and comprehensive screening than traditional diagnostic approaches. At #GSKAustralia, we are proud to support medical researchers like Professor Holmes through the GSK ARE, recognising those whose work is helping shape the current and future of Australian healthcare. Read the full article on pages 72-73: issuu.com/researchaustralia/… #GSKARE #GSKAustralia

BREAKING: The @AlboMP Government has announced a $100 million MRFF Mission for arthritis & musculoskeletal conditions - the biggest standalone Federal investment in arthritis research in Australia's history. $16B/yr on the health system. Change is here. arthritisaustralia.com.au/re…

Investing in #health and #medicalresearch does more than drive clinical outcomes: it strengthens local economies too. Research precincts create steady work for #smallbusinesses, attract talent and build resilient communities. Funding science means funding local growth as well.

Recently, we paused to observe 🧪 Clinical Trials Day 🔬 To learn more about how @ResAustralia supports #medicalresearch, #healthresearch and #clinicaltrials, visit: researchaustralia.org/cleari…

Australia could lead the world in #womenshealth #innovation, but only if more women are at the table. New analysis shows the impact of gender‑balanced leadership across research and commercialisation. Thanks @WomensAgenda for covering this issue. #equity womensagenda.com.au/latest/m…

Last night's Federal Budget delivered some important wins for Australia's health and medical research sector — but there's more work to do. 🔗 Read our full response: researchaustralia.org/catego…

@ResAustralia welcomes the announcement that the #MRFF is investing $28.5M to strengthen Aboriginal and Torres Strait Islander–led #healthresearch. Community leadership drives better outcomes and better policy. @healthgovau #IndigenousHealth health.gov.au/news/mrff/285-…

Australia’s first national population biobank is here; a major step forward for health and medical research. The Australian Health Biobank will give researchers secure access to high‑quality, nationally representative biospecimens: insightplus.mja.com.au/2026/… #HMR #data #innovation

Australia’s health & #medicalresearch (#HMR) workforce is central to our future health system, but under growing pressure. @ResAustralia's latest INSPIRE Issue explores the skills, capabilities, wellbeing needs, #equity focus & tech reshaping the industry: researchaustralia.org/inspir…

𝗟𝗮𝘀𝘁 𝗰𝗵𝗮𝗻𝗰𝗲 𝘁𝗵𝗶𝘀 𝘄𝗲𝗲𝗸𝗲𝗻𝗱 🏆 Is there someone in your network whose work deserves recognition? Nominations for the Research Australia Awards close on Monday! researchaustralia.org/awards…

👩‍🔬 INSPIRE | Issue 38 is out now! In this edition we spotlight the future of Australia’s health and medical research and innovation workforce, examining the people, skills and systems driving discovery, innovation and better health outcomes. Read now: researchaustralia.org/inspir…

A warm congratulations from the @ResAustralia team to all those recognised! #HMR #healtresearch #medicalresearch #researchers #awards djsir.vic.gov.au/news-and-ar…

Australia’s #medicalresearch sector delivers a $4 return for every $1 invested, but short #funding cycles are holding back long‑term impact. Smarter, strategic investment is essential for future breakthroughs, @ResAustralia's Nadia Levin argues here: youtube.com/watch?v=wWJVrYLG… #MRFF

Deadline extended — final chance to nominate Nominations for the 2025-26 Health and Medical Research Awards have now been extended to Monday 4 May 2026. If you’ve been thinking about nominating a colleague, team or organisation making an outstanding impact, now is the time.

“What might happen to that patient, and... how can we either prevent that from happening, or intervene earlier in the course of any disease or illness?” Great read by Professor Keith McNeil on Australia's precision #health and the role digital & data play. pulseit.news/opinion/precisi…

📢 Applications are open for Research Australia & AbbVie’s 2026 Future Health Leaders Program! 📝 Apply now: futurehealthleaders.scholars… Closes 31 May 2026 #FutureHealthLeaders #WomenInSTEM #DiversityInResearch

SMARTER INVESTMENT IN THE RESEARCH LONG GAME Government support for health and medical researchers and innovators needing investment cycle review With Nadia Levin, CEO @nlsydney Research Australia @ResAustralia OP-ED SEGMENT Filmed in Sydney | April 2026 In this Op-Ed, Nadia Levin, CEO of Research Australia, spoke with the Australian Health Journal @AUHealthJournal about the need for smarter and more strategic investment in Australia’s health and medical research sector. Levin argued that Australia’s approach to health and medical research has been shaped too heavily by short-term political cycles rather than a long-term national vision. She emphasised that meaningful progress in science, innovation, and healthcare requires sustained investment over many years. According to Levin, health and medical research should not be viewed simply as a social good, but as a major driver of economic growth, productivity, and national resilience. She highlighted that every preventable hospital admission, faster diagnosis, or locally developed medical product contributes to economic performance. Research Australia estimates that for every dollar invested in health and medical research, the Australian economy receives around four dollars in return. Levin pointed to Australia’s past achievements, including the development of IVF, the cochlear implant, the HPV vaccine, and ultrasound imaging, as examples of how research can improve lives while creating industries and export opportunities. A major focus in the need to strengthen the entire research pipeline, from early-stage discovery through to clinical translation, commercialisation, and integration into healthcare systems. Research Australia in a media release March 2026, noted that while the Medical Research Future Fund was created to distribute around $1 billion annually, it is currently providing only about $650 million each year despite holding approximately $24.5 billion. Levin referenced costings from the Parliamentary Budget Office (PBO), commissioned by Dr Monique Ryan MP, showing the fund could distribute up to $1.4 billion annually without reducing its capital base, arguing that the money, demand, and need already exist, but stronger government commitment is required. Source: Adapted from Research Australia media release March 2026 Produced & published by AUDIENCED Get your interviews captured across Australia audienced.org/contact